News & Articles

The project will generate 830 GWh of clean electricity annually, powering over 440,000 homes and reducing 166,549 tons of CO₂ emissions

New generation of allergen tests to support faster, more accurate diagnosis worldwide

Felicity Solar joins ENF Trade TV discussion on LFP vs sodium-ion batteries amid global energy storage surge

A study from Karl Landsteiner University of Health Sciences demonstrates HIFU effectively controls prostate cancer and maintains patients’ quality of life.

Findings from the study reveal how a repair system inside some bacteria plays a pivotal role in helping them survive commonly-used antibiotics

Acquisition strengthens QIAGEN’s presence in the rapidly growing single-cell market

Clearance expands menu and enables high-sensitivity troponin I measurement to aid in the diagnosis of myocardial infarction

An interdisciplinary effort to revolutionize imaging of early mammalian development through next-generation intravital microscopy

Third consecutive project demonstrates performance advantages of synthetic binders in therapeutic development applications

Partnership with Solve Scientific strengthens international sales as part of ongoing global expansion

Offers UK academic research institutions improved access to Primerdesign’s real-time PCR assays and reagents with reliable, fast and local support

AI tools are boosting productivity, but researchers raise concerns about trust and transparency in answers, representing a missed opportunity for R&D

A Queensland University of Technology collaborated resource merging scientific insight with practical laboratory methods

The kit as broad coverage for influenza strains, emerging SARS-CoV-2 variants, and detection of both RSV subgroups A and B

Collaboration between UpNano and Husun Technologies brings 2PP 3D-printing to one of the world’s largest technology markets

Acquisition to include Red One™ solid-phase cytometry platform for rapid sterility and bioburden testing, which expands Lonza’s portfolio of automated, scalable solutions for pharmaceutical quality control

Tuznue is a biosimilar of Herceptin (trastuzumab), developed to offer a more cost-effective therapeutic alternative for patients

New dengue antigen test delivers high clinical sensitivity and specificity, as well as inclusivity for all four dengue virus serotypes, helping clinicians distinguish dengue from other acute fever-causing illnesses

Collaboration will evaluate the impact of the OMED solution on the digestive health and quality of life of participants in a workplace setting